IL-17、PLR、RF在类风湿关节炎诊断中的应用及临床意义

摘要/Abstract

摘要： 目的探究白细胞介素17(IL-17)、外周血血小板/淋巴细胞比率(PLR)、类风湿因子(RF)在类风湿关节炎(RA)诊断中的应用及临床意义。方法选取于2017年6月~2019年12月在我院住院治疗的RA患者78例作为研究组,依据28关节疾病活动指数（DAS28）评分将78例RA患者分为30例活动期组和48例缓解期组,同时选取78例健康者作为对照组。记录所有患者血清IL-17、PLR、RF水平,并分析其在RA诊断中的应用及临床意义。结果研究组的IL-17、PLR、RF水平均高于对照组（P<0.05）;活动期组的IL-17、PLR、RF水平均高于缓解期组（P<0.05）;ROC结果显示：IL-17、PLR以及RF单独及联合诊断的AUC分别为0.800、0.878、0.854、0.964,联合诊断的AUC高于单项诊断（P<0.05）。结论通过检测血清IL-17、PLR、RF水平既可反映病情的进展,联合诊断又可提高RA诊断的准确率,对RA患者的诊治具有重要的临床价值。

关键词: 类风湿关节炎, 白细胞介素, 外周血血小板/淋巴细胞比率, 类风湿因子, 诊断

Abstract: Objective To explore the application and clinical significance of interleukin 17 (IL-17), peripheral blood platelet/lymphocyte ratio (PLR) and rheumatoid factor (RF) in the diagnosis of rheumatoid arthritis (RA). Methods A total of 78 RA patients who were hospitalized in the hospital from June 2017 to December 2019 were enrolled as study group. According to the disease activity score 28 (DAS28), they were divided into active stage group (30 cases) and remission stage group (48 cases). And 78 healthy people were enrolled as control group. The levels of serum IL-17, PLR and RF in all patients were recorded. And their application and clinical significance in the diagnosis of RA were analyzed. Results The levels of IL-17, PLR and RF in study group were higher than those in control group (P<0.05), which were higher in active stage group than remission stage group (P<0.05). ROC results showed that AUC values of IL-17, PLR, RF and their combination for diagnosis of RA were 0.800, 0.878, 0.854 and 0.964, respectively. AUC of combined diagnosis was higher than that of single index (P<0.05). Conclusion The detection of serum IL-17, PLR and RF levels can reflect disease progress, and their combination improve diagnosis accuracy rate of RA, which is of important clinical value in the diagnosis and treatment of RA patients.

Key words: rheumatoid arthritis, interleukin, peripheral blood platelet/lymphocyte ratio, rheumatoid factor, diagnosis

中图分类号:

R593.33

朱瑞. IL-17、PLR、RF在类风湿关节炎诊断中的应用及临床意义[J]. 承德医学院学报, 2021, 38(5): 385-388.

ZHU Rui. Application and Clinical Significance of IL-17, PLR and RF in the Diagnosis of Rheumatoid Arthritis[J]. Journal of Chengde Medical University, 2021, 38(5): 385-388.

参考文献

[1] 陈红梅,王友莲. 破骨细胞在类风湿关节炎致骨破坏病理变化中的作用及其调控[J]. 中国骨质疏松杂志,2016,22(9):1168-1173.
[2] 杜欢,许霞. 近5年来类风湿关节炎发病机制研究进展[J]. 辽宁中医药大学学报,2015,17(10):77-80.
[3] 龚桂兰,张泽宇,毛靖. 类风湿关节炎患者生活质量影响因素的路径分析[J]. 护理学杂志,2016,31(21):24-27.
[4] 王婷婷,单超,赵今. 白细胞介素-17基因多态性与牙周炎和类风湿性关节炎相关性研究进展[J]. 新乡医学院学报,2020,37(5):498-500.
[5] 王子铭,周莹,李晓军,等. 血小板/淋巴细胞比值与类风湿关节炎系统受累和疾病活动相关分析[J]. 医学研究生学报,2020,33(5):487-492.
[6] 侯勇,赵岩. 类风湿关节炎的诊断和治疗进展[J]. 实用医院临床杂志,2011,8(2):8-10.
[7] 陈光耀,罗静,郑思思,等. 类风湿关节炎患者采用体格检查与超声评估的28关节疾病活动评分比较研究[J]. 中国全科医学,2018,21(14):1727-1729.
[8] 许相洋,张文州. 类风湿关节炎的诊断及其药物治疗研究进展[J]. 中国医药导报,2016,13(30):56-59.
[9] 李必一,王若雨,赵勇. IL-17在肿瘤发生发展中的作用及其临床意义[J]. 中国医药生物技术,2016,12(1):64-68.
[10] 张国娟,黄雯. 血小板/淋巴细胞比值与维持性血液透析患者炎症状态的关系[J]. 中国血液净化,2017,16(7):459-462.
[11] 杨娟娟. 血清RF,抗 CCP 抗体和抗 MCV 抗体水平对早期类风湿关节炎的诊断价值[J]. 中国实验诊断学,2015,19(11):1847-1849.
[12] 张玉萍,姚茹冰,赵智明,等. IL-17在类风湿关节炎中的研究进展[J]. 安徽医药,2016,20(3):580-582.
[13] 范欣,俞颖哲,莫翼军,等. 中性粒细胞及血小板与淋巴细胞的比值在类风湿关节炎中的研究[J]. 中国卫生检验杂志,2019,29(18):2240-2243.
[14] 李小月,査勇,霍佩珍,等. 抗环瓜氨酸肽-CCP 抗体及类风湿因子对类风湿关节炎的临床意义[J]. 中国实验诊断学,2015,19(4):570-571,572.
[15] 刘娜,肖会,徐建华,等. 类风湿关节炎系统损害及疾病活动与血清IL-6、IL-17的相关性研究[J]. 安徽医科大学学报,2017,52(4):566-570.
[16] 王子铭,周莹,李晓军,等. 血小板/淋巴细胞比值与类风湿关节炎系统受累和疾病活动相关分析[J]. 医学研究生学报,2020,33(5):487-492.